Related Experiment Video
Updated: Oct 14, 2025
09:48
An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
Published on: September 12, 2019
8.3K
Angiosarcoma of the Uterus: A Systematic Review
Summary
Primary uterine angiosarcoma is a rare cancer. Smaller tumor size, not age or treatment, correlated with better outcomes in this systematic analysis of uterine angiosarcoma cases.
Area of Science:
- Gynecologic Oncology
- Vascular Oncology
- Rare Cancer Research
Background:
- Primary uterine angiosarcoma is an exceptionally rare malignant neoplasm.
- Existing knowledge is limited, primarily based on scattered case reports.
- Understanding prognostic factors and optimal management is crucial.
Purpose of the Study:
- To systematically analyze primary uterine angiosarcoma.
- To identify prognostic factors influencing patient outcomes.
- To inform the development of standardized treatment protocols.
Main Methods:
- Systematic literature review identifying 25 cases.
- Analysis of National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) database (4 cases).
- Inclusion of one institutional case, totaling 30 cases for analysis.
Main Results:
- No correlation found between age at diagnosis or treatment modality and patient outcomes.
- A statistically significant association between smaller tumor size and improved patient outcomes was observed.
- Primary treatments included surgery, with or without adjuvant chemotherapy and radiotherapy.
Conclusions:
- Tumor size is a critical prognostic factor in primary uterine angiosarcoma.
- Current treatment modalities and age do not appear to significantly impact survival.
- This systematic analysis provides foundational evidence for future standardized, evidence-based treatment guidelines.
